• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国人家族性脑腱黄瘤病患者的临床及分子遗传学特征。

Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families.

机构信息

Department of Neurology & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.

Department of Neurology, Jing'an District Center Hospital of Shanghai, 259 Xikang Road, Shanghai, 20040, China.

出版信息

Metab Brain Dis. 2017 Oct;32(5):1609-1618. doi: 10.1007/s11011-017-0047-8. Epub 2017 Jun 17.

DOI:10.1007/s11011-017-0047-8
PMID:28623566
Abstract

Cerebrotendinous xanthomatosis (CTX) is a lipid-storage disease caused by mutations in CYP27A1. Current publications of Chinese CTX were mainly based on case reports. Here we investigated the clinical manifestations, genetic features in Chinese CTX patients. The clinical materials of 4 Chinese CTX pedigrees were collected. The genetic testing was done by polymerase chain reaction plus Sanger sequencing. The features of Chinese CTX patients reported previously were also reviewed. Three novel mutations of p.Arg513Cys, c.1477-2A > C in family 1 and p.Arg188Stop in family 4 (NM 000784.3) in CYP27A1 were found. The probands in our study manifested cerebellar ataxia, tendon xanthoma and spastic paresis in family 1 and 4, tendon xanthoma plus spastic paraparesis in family 2, asymptomatic tendon xanthoma in family 3. Three known mutations of p.Arg137Gln, p.Arg127Trp and p.Arg405Gln were found respectively in Family 2, 3 and 4. For the Chinese patients reviewed, the most common findings were xanthomatosis (100%), pyramidal signs (100%), cerebellar ataxia (66.7%), cognitive impairment (66.7%), cataracts (50.0%), and peripheral neuropathy (33.3%). Chronic diarrhea was infrequently seen (5.6%). No mutation was found associated with any given clinical features. We identified 3 novel mutations in CYP27A1. In Chinese CTX patients, xanthomatosis was the most common symptom while cataracts and chronic diarrhea were less frequent. The special features in Chinese CTX patients might caused by the lack of serum cholestanol test and should be confirmed in larger number of patients in the future.

摘要

脑腱性黄瘤病(CTX)是一种由 CYP27A1 基因突变引起的脂质贮积病。目前中国 CTX 的文献主要基于病例报告。本研究旨在调查中国 CTX 患者的临床表现和遗传特征。收集了 4 个中国 CTX 家系的临床资料,采用聚合酶链反应加 Sanger 测序进行基因检测,并对以往报道的中国 CTX 患者的特征进行了复习。在 CYP27A1 中发现了三个新的突变,分别为家系 1 的 p.Arg513Cys、c.1477-2A>G 和家系 4 的 p.Arg188Stop(NM_000784.3)。本研究中的先证者在家族 1 和 4 中表现为小脑共济失调、腱黄瘤和痉挛性轻瘫,在家族 2 中表现为腱黄瘤伴痉挛性截瘫,在家族 3 中表现为无症状腱黄瘤。在家族 2、3 和 4 中分别发现了三个已知的突变,分别为 p.Arg137Gln、p.Arg127Trp 和 p.Arg405Gln。在回顾的中国患者中,最常见的发现是黄瘤(100%)、锥体束征(100%)、小脑共济失调(66.7%)、认知障碍(66.7%)、白内障(50.0%)和周围神经病(33.3%)。慢性腹泻少见(5.6%)。未发现与任何特定临床特征相关的突变。本研究在 CYP27A1 中发现了 3 个新突变。在中国 CTX 患者中,黄瘤是最常见的症状,而白内障和慢性腹泻较少见。中国 CTX 患者的特殊表现可能是由于缺乏血清胆甾醇检测,需要在未来更大数量的患者中进一步证实。

相似文献

1
Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families.中国人家族性脑腱黄瘤病患者的临床及分子遗传学特征。
Metab Brain Dis. 2017 Oct;32(5):1609-1618. doi: 10.1007/s11011-017-0047-8. Epub 2017 Jun 17.
2
Clinical and genetic characteristics of Chinese patients with cerebrotendinous xanthomatosis.中国人脑腱黄瘤病患者的临床和遗传特征。
Orphanet J Rare Dis. 2019 Dec 3;14(1):282. doi: 10.1186/s13023-019-1252-9.
3
Clinical and molecular genetic features of cerebrotendinous xanthomatosis in Taiwan: Report of a novel CYP27A1 mutation and literature review.台湾脑腱黄瘤病的临床与分子遗传学特征:报道一例新的 CYP27A1 突变并文献复习
J Clin Lipidol. 2019 Nov-Dec;13(6):954-959.e1. doi: 10.1016/j.jacl.2019.10.001. Epub 2019 Oct 10.
4
Cerebrotendinous Xanthomatosis patients with late diagnosed in single orthopedic clinic: two novel variants in the CYP27A1 gene.单一骨科诊所中诊断较晚的脑腱黄瘤病患者:CYP27A1 基因的两个新变异。
Orphanet J Rare Dis. 2024 Feb 9;19(1):53. doi: 10.1186/s13023-024-03082-4.
5
A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.一例患有大量黄瘤但血清胆甾烷醇水平无显著升高的脑腱性黄瘤病。
J Clin Lipidol. 2023 Nov-Dec;17(6):834-838. doi: 10.1016/j.jacl.2023.09.008. Epub 2023 Sep 17.
6
Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene.三名患有脑腱黄瘤病的兄弟姐妹:CYP27A1基因中的一种新突变。
Eur J Med Genet. 2012 Jan;55(1):71-4. doi: 10.1016/j.ejmg.2011.08.003. Epub 2011 Sep 16.
7
A novel mutation in the CYP27A1 gene in a family with cerebrotendinous xanthomatosis.一个家族性脑腱黄瘤病患者 CYP27A1 基因突变的研究
Int J Neurosci. 2020 Oct;130(10):972-975. doi: 10.1080/00207454.2020.1713774. Epub 2020 Jan 23.
8
Rare genetic cerebrotendinous xanthomatosis (CTX) cases without cholestanol elevation but with prominent cholesterol-rich tendon xanthomas.罕见的遗传性脑腱性黄瘤病(CTX)病例,胆固醇水平正常,但存在明显富含胆固醇的腱黄色瘤。
J Clin Lipidol. 2024 Jul-Aug;18(4):e631-e635. doi: 10.1016/j.jacl.2024.04.128. Epub 2024 Apr 23.
9
[Clinical and genetics characteristics of adult-onset cerebrotendinous xanthomatosis: analysis of a Chinese pedigree].[成人起病型脑腱黄瘤病的临床及遗传学特征:一个中国家系分析]
Zhonghua Nei Ke Za Zhi. 2023 Apr 1;62(4):401-409. doi: 10.3760/cma.j.cn112138-20220328-00215.
10
2 Novel deletions of the sterol 27-hydroxylase gene in a Chinese Family with Cerebrotendinous Xanthomatosis.2 例中国人胆固醇 27-羟化酶基因缺失致脑腱黄瘤病
BMC Neurol. 2011 Oct 21;11:130. doi: 10.1186/1471-2377-11-130.

引用本文的文献

1
Clinical and genetic analysis of a family with cerebrotendinous xanthomatosis.一个患有脑腱黄瘤病家族的临床与遗传学分析
Front Neurol. 2025 May 27;16:1566740. doi: 10.3389/fneur.2025.1566740. eCollection 2025.
2
Progressive ataxia of cerebrotendinous xanthomatosis with a rare c.255+1G>T splice site mutation: A case report.伴有罕见的c.255+1G>T剪接位点突变的脑腱黄瘤病的进行性共济失调:一例报告。
World J Clin Cases. 2022 Oct 16;10(29):10681-10688. doi: 10.12998/wjcc.v10.i29.10681.
3
Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?

本文引用的文献

1
[Analysis of a cerebrotendinous xanthomatosis case with mental retardation as the initial symptom].[以智力发育迟缓为首发症状的脑腱性黄瘤病病例分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Aug;33(4):476-80. doi: 10.3760/cma.j.issn.1003-9406.2016.04.010.
2
Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports.脑腱黄瘤病,一种具有不同神经症状的代谢性疾病:两例病例报告
Metab Brain Dis. 2016 Oct;31(5):1185-8. doi: 10.1007/s11011-016-9841-y. Epub 2016 May 26.
3
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
冠状动脉疾病的病因之谜:遗传因素有多重要?
Life (Basel). 2022 Jun 9;12(6):865. doi: 10.3390/life12060865.
4
Late-Onset Leukodystrophy Mimicking Hereditary Spastic Paraplegia without Diffuse Leukodystrophy on Neuroimaging.影像学无弥漫性脑白质营养不良表现的迟发性脑白质营养不良,酷似遗传性痉挛性截瘫
Neuropsychiatr Dis Treat. 2021 May 12;17:1451-1458. doi: 10.2147/NDT.S296424. eCollection 2021.
5
Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings.缺乏典型生化表现的脑腱黄瘤病的家族变异性
JIMD Rep. 2021 Jan 8;59(1):3-9. doi: 10.1002/jmd2.12197. eCollection 2021 May.
6
Cerebrotendinous xanthomatosis with peripheral neuropathy: a clinical and neurophysiological study in Chinese population.伴有周围神经病变的脑腱黄瘤病:一项针对中国人群的临床及神经生理学研究
Ann Transl Med. 2020 Nov;8(21):1372. doi: 10.21037/atm-20-2746.
7
Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.经基因检测确诊的脑腱黄瘤病中国患者:病例报告及文献综述
World J Clin Cases. 2020 Nov 6;8(21):5446-5456. doi: 10.12998/wjcc.v8.i21.5446.
8
Clinical and genetic characteristics of Chinese patients with cerebrotendinous xanthomatosis.中国人脑腱黄瘤病患者的临床和遗传特征。
Orphanet J Rare Dis. 2019 Dec 3;14(1):282. doi: 10.1186/s13023-019-1252-9.
序列变异解读的标准与指南:美国医学遗传学与基因组学学会和分子病理学协会的联合共识推荐
Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.
4
Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.脑腱黄瘤病:发病机制、临床表现、诊断及治疗的全面综述
Orphanet J Rare Dis. 2014 Nov 26;9:179. doi: 10.1186/s13023-014-0179-4.
5
A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis.脑腱性黄瘤病早期诊断与治疗的疑似指数
J Inherit Metab Dis. 2014 May;37(3):421-9. doi: 10.1007/s10545-013-9674-3. Epub 2014 Jan 18.
6
Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivo.体内固醇 27-羟化酶在糖皮质激素代谢中的作用证据。
J Endocrinol. 2013 Oct 4;219(2):119-29. doi: 10.1530/JOE-13-0141. Print 2013 Nov.
7
Cerebrotendinous xanthomatosis.脑腱黄瘤病。
Curr Opin Lipidol. 2013 Aug;24(4):283-7. doi: 10.1097/MOL.0b013e328362df13.
8
Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review.不典型帕金森病和脑腱黄瘤病:伴有皮质基底节综合征的一家系报告及文献复习。
Mov Disord. 2012 Dec;27(14):1769-74. doi: 10.1002/mds.25229. Epub 2012 Nov 2.
9
Early-onset epilepsy as the main neurological manifestation of cerebrotendinous xanthomatosis.早发性癫痫作为脑腱黄瘤病的主要神经表现。
Epilepsy Behav. 2012 Jul;24(3):380-1. doi: 10.1016/j.yebeh.2012.04.121. Epub 2012 May 30.
10
A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 gene.1例以癫痫为首发症状的脑腱黄瘤病,伴有CYP27A1基因新的V413D突变。
Clin Neurol Neurosurg. 2012 Sep;114(7):1021-3. doi: 10.1016/j.clineuro.2012.01.032. Epub 2012 Feb 13.